32-O-Demethyl-Sirolimus | CAS 141392-23-6 - Request Quote
32-O-Demethyl-Sirolimus
| SZ CAT No: | SZ-R025006 |
| CAS No | 141392-23-6 |
| Mol.F. | C50H77NO13 |
| Mol.Wt. | 900.2 |
| Inv. Status | Synthesis on demand |
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
32-O-Demethyl-Sirolimus is chemically . It is also known as 32-O-Demethyl-Rapamycin. 32-O-Demethyl-Sirolimus is supplied with detailed characterization data compliant with regulatory guideline. 32-O-Demethyl-Sirolimus can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rapamycin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 141392-23-6
Purchase 141392-23-6
Order 141392-23-6
Enquire 141392-23-6
price of 141392-23-6
141392-23-6 Supplier
141392-23-6 Manufacturer
141392-23-6 Exporter
buy high quality 32-O-Demethyl-Sirolimus
Purchase 32-O-Demethyl-Sirolimus
32-O-Demethyl-Sirolimus suppliers
32-O-Demethyl-Sirolimus manufacturers
32-O-Demethyl-Sirolimus price
Order 32-O-Demethyl-Sirolimus
Enquire 32-O-Demethyl-Sirolimus
32-O-Demethyl-Sirolimus cost
32-O-Demethyl-Sirolimus Supplier
32-O-Demethyl-Sirolimus Distributor
32-O-Demethyl-Sirolimus for Method Validation
Rapamycin Reference Standard
32-O-Demethyl-Sirolimus for ANDA Filing
32-O-Demethyl-Sirolimus for Forced Degradation Studies
32-O-Demethyl-Sirolimus Identification Standards
32-O-Demethyl-Sirolimus for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.